Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
7720-78-7
Molecular formula
FeO4S
Molecular weight
151.91 g/mol
Drug class
Iron replacementferrous (Fe2+) iron source
Mechanism of action
Ferrous iron is absorbed primarily in the duodenum and proximal jejunum through divalent metal transporter 1 (DMT1). Absorbed iron enters the circulating transferrin pool and is incorporated into haemoglobin, myoglobin and iron-dependent enzymes. Fumarate, sulfate, succinate and ascorbate salts deliver the same ferrous iron moiety; elemental iron content and formulation affect dosing and tolerability, not the core deficiency indication.
Indications / reported uses
Prevention and treatment of iron deficiency
Treatment of iron-deficiency anaemia, including in pregnancy where clinically appropriate; elemental iron dose and tolerability depend on the particular salt and formulation
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Ferrous Sulfate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Ferrous Sulfate Permitted Daily Exposure (PDE) report (the Ferrous Sulfate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Ferrous Sulfate Occupational Exposure Limit (OEL) report (the Ferrous Sulfate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.